Research and Development

Merck received welcome news this week from the FDA after one of the US regulator’s expert groups voted to approve …

Janssen has outlined plans to submit ‘more than ten’ new product filings worldwide in the next four years, along with …

Pre-clinical products firm Hurel has appointed Dr James MacDonald to the company’s Board of directors.  MacDonald is the former executive …

GlaxoSmithKline is to be given up to $200 million by the US government to develop new antibiotics as worries grow …

Johannes Schubmehl has been appointed chief information officer of Bayer HealthCare. Schubmehl succeeded Matthias Moritz, who left the company at …

Actavis is to buy Dublin-based firm Warner Chilcott in an $8.5 billion deal which will see the Warner name disappear …

The ABPI is to take on responsibility for representing the vaccine industry to UK government and healthcare stakeholders.For more than …

Pfizer’s oncology pipeline has suffered a blow with the company abandoning a Phase III study of one of its investigational …

Boehringer’s Professor Wolfram Carius is stepping down from the Board to be replaced by Dr Wolfgang Baiker. Carius who is …

Eisai has appointed Ricardo Gonzalez Balboa to the position of general manager, Eisai Mexico. In this position, Gonzalez Balboa will …

The National Health Service, perhaps the UK’s most deeply loved institution, is facing a double threat. On one hand, there …

Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …

Clinical supplies firm Biotec Services International has expanded its presence in Israel with the appointment of a new Israeli agent. …

Biotech firm Intra-Cellular Therapies has appointed former NICE chairman Professor Sir Michael Rawlins to its Board of directors. Rawlins was …

Elan has struck a novel deal with Theravance which gives it a share of potential future royalties from its respiratory …